Search Results

Supplementation of rapamycin during in vitro maturation promotes oocyte quality and subsequent embryo development in bovine.

• Authors : Khatun, Hafiza; Islam, Md Rasadul; Khan, Muckta

• Source: Bulletin of the National Research Centre. December, 2023, Vol. 47 Issue 1.

Record details

Reports from University of Tsukuba Describe Recent Advances in Physiology Nutrition and Metabolism (The role of the mechanistic target of rapamycin complex 1 in the regulation of mitochondrial adaptation during skeletal muscle atrophy under ...)

• Source: Health & Medicine Week. 2024, pages. 4609

Record details

Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma.

• Authors : Tobinai K; Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. ; Ogura M

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*drug therapy

• Source: International journal of hematology [Int J Hematol] 2010 Nov; Vol. 92 (4), pp. 563-70. Date of Electronic Publication: 2010 Oct 23.Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model:

Record details

Fpr1, a primary target of rapamycin, functions as a transcription factor for ribosomal protein genes cooperatively with Hmo1 in Saccharomyces cerevisiae.

• Authors : Kasahara, Koji; Nakayama, Risa; Shiwa, Yuh

• Source: PLoS Genetics. June 30, 2020, Vol. 16 Issue 6, e1008865.

Record details

Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1.

• Authors : Maekawa, Hirotsugu; Kawai, Shunsuke; Nishio, Megumi

• Source: Orphanet Journal of Rare Diseases. May 24, 2020, Vol. 15 Issue 1.

Record details

Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan.

• Authors : Egami, Akemi¹ (AUTHOR); Takahashi, Shinji¹ (AUTHOR); Kokubo, Takeshi¹ (AUTHOR)

Subjects: *CUTANEOUS manifestations of general diseases; *RAPAMYCIN; *TUBEROUS sclerosisJAPAN

• Source: Dermatology & Therapy. May2023, Vol. 13 Issue 5, p1113-1126. 14p.

Record details

Investigators at Saga University Detail Findings in Adult T-Cell Leukemia-Lymphoma (Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin).

• Source: Biotech Week. 2016, pages. 628

Record details

Reports Outline Saccharomyces cerevisiae Study Results from Kyoto University (Methylglyoxal Activates the Target of Rapamycin Complex 2-Protein Kinase C Signaling Pathway in Saccharomyces cerevisiae).

• Source: Proteomics Weekly. 2015, pages. 46

Record details

New Findings from Kitasato University Update Understanding of Immune System (Preventive Effects of Rapamycin on Inflammation and Capillary Degeneration in a Rat Model of NMDA-Induced Retinal Injury).

• Source: Health & Medicine Week. 2015, pages. 3560

Record details

New Fragile X Syndrome Study Findings Have Been Published by Researchers at University of Tokyo Hospital (Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin).

• Source: Mental Health Weekly Digest. May 2, 2022, 254.

Record details